You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 117 No. 11, November 1982 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (70)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Platelet—Arterial Synthetic Graft Interaction and Its Modification

Allan D. Callow, MD; Raymond Connolly, PhD; Thomas F. O'Donnell, Jr, MD; Ronald Gembarowicz, MD; Ellen Keough, PhD; Karen Ramberg-Laskaris, MS; C. Robert Valeri, MD

Arch Surg. 1982;117(11):1447-1455.


Abstract

• We compared the in vivo platelet reactivity of two commonly used clinical grafts, Dacron and expanded polytetrafluoroethylene (PTFE), with that of a control autogenous artery graft and assessed whether platelet reactivity was modified by the platelet-antiaggregating agent prostacyclin (PGI2) (epoprostenol). Grafts were randomly placed into the carotid arteries of 21 baboons. Platelets labeled with indium 111 were infused within one hour after implantation graft for gamma camera scanning of platelet uptake. The accumulation of platelets on Dacron grafts began almost immediately after injection and reached a peak after one to two hours. The PTFE and control autogenous artery grafts accumulated comparable small amounts of platelets. Prostacyclin was then infused in a second series of baboons with Dacron grafts, at a rate of 150 to 200 ng/kg/min. It prevented the usual platelet uptake when administered concomitant with graft implantation and reduced previously established platelet activity.

(Arch Surg 1982;117:1447-1455)



Author Affiliations

From the Departments of Surgery (Drs Callow, Connolly, O'Donnell, Gembarowicz, and Keough) and Nuclear Medicine (Ms Ramberg-Laskaris), Tufts-New England Medical Center, and the US Naval Blood Research Laboratory (Dr Valeri), Boston.


Footnotes

Accepted for publication Aug 5, 1982.

Read before the 30th scientific meeting of the International Cardiovascular Society, Boston, June 18, 1982.

Reprint requests to 171 Harrison Ave, Boston, MA 02111 (Dr Callow).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Early Restenosis After Carotid Endarterectomy with Vein Patch Angioplasty
Tripathi and Deshmukh
VASC ENDOVASCULAR SURG 1997;31:761-767.
ABSTRACT  

The Possibility of Distal Embolization From a Femoral-Popliteal Prosthesis Above the Knee: A Consideration Against Its Routine Use in This Position
Friedman and Krishnasastry
Arch Surg 1990;125:668-670.
ABSTRACT  

Plasma Polymerized Tetrafluoroethylene/Polyethylene Terephthalate Vascular Prostheses
Greisler et al.
Arch Surg 1989;124:967-972.
ABSTRACT  

Effect of a Selective Thromboxane Synthase Inhibitor on Arterial Graft Patency and Platelet Deposition in Dogs
McDaniel et al.
Arch Surg 1987;122:887-892.
ABSTRACT  

Effect of Prolonged Intra-arterial Prostaglandin E1 Infusion on Canine Arterial Graft Patency
Cronenwett et al.
Arch Surg 1986;121:760-764.
ABSTRACT  

Synthetic Arterial Graft Conduits
Jackson
VASC ENDOVASCULAR SURG 1984;18:354-358.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1982 American Medical Association. All Rights Reserved.